Zurich scientists have succeeded in “re-programming” a bacteria-killing virus to make it attack a different target instead of its usual prey.
This content was published on
1 minute
Keystone-SDA/dos
The method is still in its infancy, but could have consequences for a more targeted tackling of bacterial infections, the Swiss Federal Technology Institute ETH Zurich wrote on MondayExternal link.
Essentially, the scientists managed to manipulate the behaviour of a certain virus that survives and propagates through attacking specific bacteria cells.
By identifying the features of the “anti-Listeria” bacteriophage (a type of virus), then adapting it by adding similar but different features from other bacteriophages, the researchers made it head for a different layer of the Listeria bacteria than the one it usually attacks.
The advantage of this approach is that it allows a very precise targeting of pathogenic bacteria, ETH wrote, especially when compared to standard antibiotics. The latter are indiscriminate in attacking both good and bad bacteria.
Moreover, bacteria can build up a resistance to antibiotics over time, something that this targeted system also gets around.
Although bacteriophage therapy was used successfully in one recent case – that of an American teenager suffering from cystic fibrosis who had contracted a severe infection – the ETH scientists say that a large-scale use of the method is not going to happen soon.
12,000 fish to be transferred by helicopter in Swiss river cleanup operation
This content was published on
Some 12,000 fish are being removed from the River Spöl in the Swiss National Park. This operation is necessary before cleaning up the riverbed, which was contaminated by PCBs during maintenance work in 2016.
Swiss parliament approves due diligence for high-risk consultancy activities
This content was published on
On Thursday, the House of Representatives accepted the draft of the Senate, which was largely watered down compared to the government's original proposal.
Zurich Film Festival will show 114 films and honour Russell Crowe
This content was published on
The 21st Zurich Film Festival (ZFF) will screen 114 films, including 16 Swiss productions and 41 European or world premieres, from 25 September to 5 October. Actor Russell Crowe will receive an honorary lifetime achievement award.
Emergency financial aid authorised for Swiss village buried by landslide
This content was published on
The Valais Grand Council gives the green light for a solidarity contribution of CHF 10 million for the village of Blatten, which was destroyed by the landslide. The aid is to benefit the population, companies and associations.
New attempt to regulate assisted suicide in Switzerland fails
This content was published on
Assisted suicide will not be regulated in Switzerland. On Thursday, the Senate rejected a motion from its Legal Affairs Committee.
Risk of sepsis is underestimated in Switzerland, warn experts
This content was published on
In Switzerland, over 20,000 people are hospitalised with sepsis every year. Around 4,000 die as a result, as a new report from the Swiss Sepsis Programme shows.
Swiss SME sentiment remains stable despite steep US tariffs
This content was published on
Despite the high US tariffs, the mood among Swiss SMEs has hardly deteriorated. However, two thirds of export-oriented companies have now adjusted their export strategy, with one in ten even questioning it as a whole.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
CHF200,000 awarded to protein synthesis pioneer
This content was published on
Nenad Ban of the federal technology institute ETH Zurich has been selected to receive the Otto Naegeli prize for his work on ribosomes.
Discovery could help counter antibiotic resistance
This content was published on
Swiss researchers have brought to light new antibiotic substances in bacteria on a still rarely explored site: the surface of a common field weed.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.